Innovate UK, GB: SBRI: Clinical biomarker tools and technologies for dementia

20/07/2023

04/09/2023

This is a Small Business Research Initiative (SBRI) competition funded by Innovate UK. The aim of the competition is to accelerate innovations in dementia biomarker detection to transform the clinical development of precision therapies. These technologies will enable the discovery, validation and implementation of a suite of decision-enabling biomarkers. Your project can involve exemplar biomarkers that can be adapted towards a broader range of clinically actionable dementia markers. Award amount max £1,000,000 Award amount min £100,000 Amount note A total of up to £6 million, inclusive of VAT, is allocated to this competition.

Your project can focus on one or more of the following: technologies to subtype and stratify dementia patient cohorts technologies to measure early-stage trial endpoints in dementia clinical trials technologies to predict efficacy of emerging therapies currently in the drug discovery and clinical pipeline technologies for longitudinal monitoring of treatment outcomes in dementia repurposing of technologies that will enable the robust detection of emerging dementia clinical biomarkers.

Eligibility Note To lead a project, you can: be an organisation of any size work alone or with others from business, research organisations, research and technology organisations or the third sector as subcontractors This competition will not fund any procurement, commercial, business development or supply chain activity with any Russian or Belarusian entity as lead or subcontractor. This includes any goods or services originating from a Russian or Belarusian source.